Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04926181
Title Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Rahul Aggarwal

prostate adenocarcinoma

castration-resistant prostate carcinoma

prostate neuroendocrine neoplasm


Apalutamide + Cetrelimab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Francisco Recruiting San Francisco California 94143 United States Details
*Shaded cells indicate that there was no data available from for the field